Bexagliflozin (Brenzavvy) and dapagliflozin (Farxiga) induced similar HbA1c reductions over 24 weeks in a head-to-head phase III trial of the SGLT2 inhibitors in Chinese adults with type 2 diabetes on ...
Following the FDA’s September announcement of a crackdown on direct-to | Monday, the FDA’s Office of Prescription Drug ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The prevalence ...
(RTTNews) - The US Food and Drug Administration AstraZeneca's Farxiga (dapagliflozin) to improve glycemic control in pediatric patients with type-2 diabetes or T2D aged 10 years and older. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback